Since PTEN is a constitutive inhibitor of mTOR, its loss of function causes the hyperactivation of mTOR and somatic mutations of PTEN cause a variety of cortical malformations depending in severity on the extent of the mutation, ranging from hemimegalencephaly to T2FCD43,65,66. This evidence concerns the gene PTEN and hemimegalencephaly.